Back to Search Start Over

Glioblastoma hijacks neuronal mechanisms for brain invasion.

Authors :
Venkataramani V
Yang Y
Schubert MC
Reyhan E
Tetzlaff SK
Wißmann N
Botz M
Soyka SJ
Beretta CA
Pramatarov RL
Fankhauser L
Garofano L
Freudenberg A
Wagner J
Tanev DI
Ratliff M
Xie R
Kessler T
Hoffmann DC
Hai L
Dörflinger Y
Hoppe S
Yabo YA
Golebiewska A
Niclou SP
Sahm F
Lasorella A
Slowik M
Döring L
Iavarone A
Wick W
Kuner T
Winkler F
Source :
Cell [Cell] 2022 Aug 04; Vol. 185 (16), pp. 2899-2917.e31. Date of Electronic Publication: 2022 Jul 31.
Publication Year :
2022

Abstract

Glioblastomas are incurable tumors infiltrating the brain. A subpopulation of glioblastoma cells forms a functional and therapy-resistant tumor cell network interconnected by tumor microtubes (TMs). Other subpopulations appear unconnected, and their biological role remains unclear. Here, we demonstrate that whole-brain colonization is fueled by glioblastoma cells that lack connections with other tumor cells and astrocytes yet receive synaptic input from neurons. This subpopulation corresponds to neuronal and neural-progenitor-like tumor cell states, as defined by single-cell transcriptomics, both in mouse models and in the human disease. Tumor cell invasion resembled neuronal migration mechanisms and adopted a Lévy-like movement pattern of probing the environment. Neuronal activity induced complex calcium signals in glioblastoma cells followed by the de novo formation of TMs and increased invasion speed. Collectively, superimposing molecular and functional single-cell data revealed that neuronal mechanisms govern glioblastoma cell invasion on multiple levels. This explains how glioblastoma's dissemination and cellular heterogeneity are closely interlinked.<br />Competing Interests: Declaration of interests F.W. and W.W. report the patent (WO2017020982A1) “Agents for use in the treatment of glioma.” F.W. is co-founder of DC Europa Ltd (a company trading under the name Divide & Conquer) that is developing new medicines for the treatment of glioma. Divide & Conquer also provides research funding to F.W.’s lab under a research collaboration agreement.<br /> (Copyright © 2022 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1097-4172
Volume :
185
Issue :
16
Database :
MEDLINE
Journal :
Cell
Publication Type :
Academic Journal
Accession number :
35914528
Full Text :
https://doi.org/10.1016/j.cell.2022.06.054